These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29509110)

  • 1. Potential cost-effectiveness of using a collagen-containing dressing in managing diabetic foot ulcers in the UK.
    Guest JF; Singh H; Vowden P
    J Wound Care; 2018 Mar; 27(3):136-144. PubMed ID: 29509110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of using a collagen-containing dressing plus compression therapy in non-healing venous leg ulcers.
    Guest JF; Rana K; Singh H; Vowden P
    J Wound Care; 2018 Feb; 27(2):68-78. PubMed ID: 29424641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential cost-effectiveness of using adjunctive dehydrated human amnion/chorion membrane allograft in the management of non-healing diabetic foot ulcers in the United Kingdom.
    Guest JF; Atkin L; Aitkins C
    Int Wound J; 2021 Dec; 18(6):889-901. PubMed ID: 33827144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic foot ulcer management in clinical practice in the UK: costs and outcomes.
    Guest JF; Fuller GW; Vowden P
    Int Wound J; 2018 Feb; 15(1):43-52. PubMed ID: 29243399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of using adjunctive porcine small intestine submucosa tri-layer matrix compared with standard care in managing diabetic foot ulcers in the US.
    Guest JF; Weidlich D; Singh H; La Fontaine J; Garrett A; Abularrage CJ; Waycaster CR
    J Wound Care; 2017 Jan; 26(Sup1):S12-S24. PubMed ID: 28105902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cost-effectiveness analysis of a hydration response technology dressing in the treatment of venous leg ulcers in the UK.
    Walzer S; Dröschel D; Vollmer L; Atkin L; Ousey K
    J Wound Care; 2018 Mar; 27(3):166-172. PubMed ID: 29509113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost effectiveness of Apligraf treatment of diabetic foot ulcers.
    Redekop WK; McDonnell J; Verboom P; Lovas K; Kalo Z
    Pharmacoeconomics; 2003; 21(16):1171-83. PubMed ID: 14594438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of Debrichem in managing hard-to-heal venous leg ulcers in the UK.
    Guest JF; Deanesi V; Segalla A
    J Wound Care; 2022 Jun; 31(6):480-491. PubMed ID: 35678784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of using intermittent pneumatic compression to manage hard-to-heal venous leg ulcers in the UK.
    Guest JF; Staines K; Murphy N
    J Wound Care; 2021 Jul; 30(7):544-552. PubMed ID: 34256598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of treating deep diabetic foot ulcers with Promogran in four European countries.
    Ghatnekar O; Willis M; Persson U
    J Wound Care; 2002 Feb; 11(2):70-4. PubMed ID: 11901743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the efficacies of alginate, foam, hydrocolloid, hydrofiber, and hydrogel dressings in the management of diabetic foot ulcers and venous leg ulcers: a systematic review and meta-analysis examining how to dress for success.
    Saco M; Howe N; Nathoo R; Cherpelis B
    Dermatol Online J; 2016 Aug; 22(8):. PubMed ID: 27617934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of TLC-NOSF dressings versus neutral dressings for the treatment of diabetic foot ulcers in France.
    Maunoury F; Oury A; Fortin S; Thomassin L; Bohbot S;
    PLoS One; 2021; 16(1):e0245652. PubMed ID: 33481840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic Evaluation of Sucrose Octasulfate Dressing for Treatment of Diabetic Foot Ulcers in Patients with Type 2 Diabetes.
    Wen J; Jin X; Al Sayah F; Johnson JA; Paulden M; Ohinmaa A
    Can J Diabetes; 2022 Mar; 46(2):126-133. PubMed ID: 35148951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of Novel Macrophage-Regulating Treatment for Wound Healing in Patients With Diabetic Foot Ulcers From the Taiwan Health Care Sector Perspective.
    Su HY; Yang CY; Ou HT; Chen SG; Chen JC; Ho HJ; Kuo S
    JAMA Netw Open; 2023 Jan; 6(1):e2250639. PubMed ID: 36633847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the cost-effectiveness of electric stimulation therapy in non-healing venous leg ulcers.
    Taylor RR; Sladkevicius E; Guest JF
    J Wound Care; 2011 Oct; 20(10):464, 466, 468-72. PubMed ID: 22067884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and cost-effectiveness of absorbent dressings in the treatment of highly exuding VLUs.
    Panca M; Cutting K; Guest JF
    J Wound Care; 2013 Mar; 22(3):109-10, 112-8. PubMed ID: 23665729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of wound duration on diabetic foot ulcer healing: evaluation of a new sucrose octasulfate wound dressing.
    Lobmann R; Grünerbel A; Lawall H; Lüdemann C; Morbach S; Tigges W; Völkel L; Rychlik RP
    J Wound Care; 2020 Oct; 29(10):543-551. PubMed ID: 33052796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagen dressing in the treatment of diabetic foot ulcer: A prospective, randomized, placebo-controlled, single-center study.
    Park KH; Kwon JB; Park JH; Shin JC; Han SH; Lee JW
    Diabetes Res Clin Pract; 2019 Oct; 156():107861. PubMed ID: 31536746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of antimicrobial dressings for the management of diabetic foot ulcers: A survey of podiatrists in Aotearoa New Zealand.
    Ma S; Frecklington M; Stewart S
    J Foot Ankle Res; 2024 Jun; 17(2):e12032. PubMed ID: 38884388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
    Curran MP; Plosker GL
    BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.